J. Am. Chem. Soc. 1997, 119, 12697-12698
Enzymatic, Polymer-Supported Formation of an
12697
Analog of the Trypsin Inhibitor A90720A: A
Screening Strategy for Macrocyclic Peptidase
Inhibitors
Matthew T. Burger and Paul A. Bartlett*
Department of Chemistry, UniVersity of California
Berkeley, California 94720-1460
ReceiVed April 17, 1997
Macrocyclic constraint is effective in reducing conformational
flexibility and thereby enhancing binding affinity and metabolic
stability in enzyme inhibitors and other protein ligands.1 Such
derivatives present challenges both in design and synthesis: ring
systems must be identified that induce the correct conformation
in the binding region while avoiding unfavorable contacts with
the receptor, and a significant investment in effort is required
to prepare the analogs. A rapid and convenient method for
identifying favorable ring systems prior to synthesis would be
useful, especially if the method could be applied as a combi-
natorial approach. In this paper, we propose such a strategy
for the discovery of macrocyclic peptidase inhibitors, demon-
strating the key features of the method with the synthesis of an
analog (2) of A90720A (1), a naturally-occurring inhibitor of
trypsin.2
Figure 1. Strategy for distinguishing, from a library of analogs,
molecules that cyclize from those that do not.
linkage were replaced with a transition state analog). Since both
the forward (hydrolysis) and reverse (amide synthesis) reactions
catalyzed by a peptidase involve the same intermediate,
discovering which linear derivatives are readily cyclized by the
enzyme should also point to structures that would make good
macrocyclic inhibitors.3 Linear molecules are inherently easier
to synthesize than macrocycles, and a variety of strategies are
available for inducing peptide bond formation by a peptidase
(activated precursors, lower pH, low-water content, etc.4).
Key for the success of this strategy is a simple assay for
cyclization that can identify individual beads from an encoded
library and thus take full advantage of the combinatorial
approach.5 The scheme depicted in Figure 1 relies on the
cyclization reaction to establish a connection between the
polymeric synthesis support and a dye that is stable to conditions
which cleave the molecule at a different point. Cleavage
removes the dye from beads carrying derivatives that did not
cyclize, while dye is retained on those that have the desired
analogs. We have reduced to practice the major elements in
this strategy by synthesizing macrocycle 2 on a solid phase by
enzymatic cyclization and demonstrating that beads with cy-
clized and uncyclized molecules can be differentiated by
hydrolysis of the ester linkage.
A90720A (1) furnished an ideal test system for this approach;
it binds to trypsin with the Thr-Arg-Ahp [Ahp ) 3-amino-6-
hydroxy-2-piperidone] tripeptide in the S2-S1-S1′ subsites, with
the tyrosine N-methyl projecting away from the enzyme, and
the sulfoglyceryl-Leu residues in an open region on the protein
surface.2 These positions on A90720A were thus logical places
to locate the dye molecule (a derivative of Disperse Red 1) and
the tether point, respectively, since they are on opposite sides
of the cleavable ester linkage. Design of the synthetic target 2
was completed by substituting Ser for the Ahp subunit for ease
of synthesis, and replacing the sulfoglyceryl-Leu moiety with
a simple acid- and base-stable attachment to a photocleavable
tether to the resin. The acyclic precursor was assembled in
solution in protected form (see the Supporting Information),
We reasoned that a ring system that is favorably bound and
turned over as a substrate by the enzyme should be similarly
effective in the form of an inhibitor (for example, if the scissile
(1) Inter alia: Ksander, G. M.; de Jesus, R.; Yuan, A.; Ghai, R. D.;
Trapani, A.; McMartin, C.; Bohacek, R. J. Med. Chem. 1997, 40, 495.
Ksander, G. M.; de Jesus, R.; Yuan, A.; Ghai, R. D.; McMartin, C.; Bohacek,
R. J. Med. Chem. 1997, 40, 506. Ettmayer, P.; Billich, A.; Hecht, P.;
Rosenwirth, B.; Gstach, H. J. Med. Chem. 1996, 39, 3291. Kim, C. U.;
McGee, L. R.; Krawczyk, S. H.; Harwood, E.; Harada, Y.; Swaminathan,
S.; Bischofberger, N.; Chen, M. S.; Cherrington, J. M.; Xiong, S. F.; Griffin,
L.; Cundy, K. C.; Lee, A.; Yu, B.; Gulnick, S.; Erickson, J. W. J. Med.
Chem. 1996, 39, 3431. March, D. R.; Abbenante, G.; Bergman, D. A.;
Brinkworth, R. I.; Wickramasinghe, W.; Begun, J.; Martin, J. L.; Fairlie,
D. P. J. Am. Chem. Soc. 1996, 118, 3375. Morgan, B. P.; Bartlett, P. A.;
Holland, D. R.; Matthews, B. W. J. Am. Chem. Soc. 1994, 116, 3251.
Podlogar, B. L.; Farr, R. A.; Friedrich, D.; Tarnus, C.; Huber, E. W.; Cregge,
R. J.; Schirlin, D. J. Med. Chem. 1994, 37, 3684. Hruby, V. J.; Bonner, G.
G. Methods Mol. Biol. 1994, 35, 201. Davies, J. S. Amino Acids, Pept.,
Proteins 1994, 25, 246. MacPherson, L. J.; Bayburt, E. K.; Capparelli, M.
P.; Bohacek, R. S.; Clarke, F. H.; Chai, R. D.; Sakane, Y.; Berry, C. J.;
Peppard, J. V.; Trapani, A. J. J. Med. Chem. 1993, 36, 3821. Yang, L.;
Weber, A. E.; Greenlee, W. J.; Patchett, A. A. Tetrahedron Lett. 1993, 34,
7035.
(3) Because some ring systems are inherently easier to form, no direct
relationship between the rate of enzymatic cyclization and transition state
binding affinity is expected (Radzicka, A.; Wolfenden, R. Methods Enzymol.
1995, 249, 284); however, the fact that ring systems which are easily formed
would be favored in this screen may have practical benefits in identifying
macrocyclic inhibitors that are easier to synthesize.
(4) Heiduschka, P.; Dittrich, J.; Barth, A. Pharmazie 1990, 45, 164.
(5) Joyce, G. F.; Still, W. C.; Chapman, K. T. Curr. Opin. Chem. Biol.
1997, 1, 3 and companion articles in that issue.
(2) Bonjouklian, R.; Smitka, T. A.; Hunt, A. H.; Occolowitz, J. L.; Perun,
T. J., Jr.; Doolin, L.; Stevenson, S.; Knauss, L.; Wijayaratne, R.; Szewczyk,
S.; Patterson, G. M. L. Tetrahedron 1996, 52, 395. Lee, A. Y.; Smitka, T.
A.; Bonjouklian, R.; Clardy, J. Chem. Biol. 1994, 1, 113.
S0002-7863(97)01216-X CCC: $14.00 © 1997 American Chemical Society